New implant targets prostate cancer from the inside

NCT ID NCT06257693

Recruiting now Disease control Sponsor: Alessa Therapeutics Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This early-stage study tests a small implant called Enolen that delivers the drug enzalutamide directly into the prostate. The goal is to see if it is safe and how much drug reaches the tumor. About 56 men with prostate cancer who are already scheduled for prostate removal surgery will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE ADENOCARCINOMA

Contacts and locations

Locations

Atlantic Urology Specialists
RECRUITING

Myrtle Beach, South Carolina, 29572, United States
Aurora Urology
RECRUITING

Milwaukee, Wisconsin, 53215, United States
Johns Hopkins University School of Medicine
RECRUITING

Baltimore, Maryland, 21287, United States
Mary Bird Cancer Center
RECRUITING

Metairie, Louisiana, 70002, United States
National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States
Northwestern University
RECRUITING

Chicago, Illinois, 60611, United States
University of California San Francisco Helen Diller Family Comprehensive Cancer Center
RECRUITING

San Francisco, California, 94158, United States
Urology Associates of Central California
RECRUITING

Fresno, California, 93720, United States
VA Portland Health Care System
RECRUITING

Portland, Oregon, 97239, United States
Virginia Commonwealth University
RECRUITING

Richmond, Virginia, 23298, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.